Fulgent Genetics, Inc.
SEC CIK 1674930 · FLGT · last insider filing 2026-06-03
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Hsieh Ming | Director · President and CEO | filed 2016 - 2026 |
| Groves Regina E | Director | filed 2023 - 2026 |
| Marsh Linda | Director | filed 2019 - 2026 |
| Nohaile Michael | Director | filed 2022 - 2026 |
| Bolger John C | Director | filed 2016 - 2022 |
| Post Leonard E | Director | filed 2022 - 2022 |
| Yen Yun | Director | filed 2016 - 2022 |
| Mulay James | Director | filed 2016 - 2019 |
| Fulgent Genetics, Inc. | Director | filed 2017 - 2017 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Kim Paul | CFO and Treasurer | filed 2016 - 2026 |
| Gao Hanlin | Chief Scientific Officer | filed 2016 - 2026 |
| Xie Jian | President and COO | filed 2020 - 2026 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.